ResearchMoz

Patent Analysis Market Research Reports & Industry Analysis

In the technological parlance, patent or patenting is a text that carries a typical structure with a specific objective. The patent is all about protecting an actual physical invention, not just an idea. Hence, when technological companies, industries, or governments declare an invention or innovation for something in specific, they back it up with detailed mechanical drawings and evidence along with a written document. 
However, on the contrary, knowing patents and availing them through sources like Internet/Companies is defined as patent analysis. These patents are enforced in the market before determining any new development, product, or service through important investments that could easily block an existing patent. There are many patent organizations that allow free downloading of the complete text and abstracts of their respective patent profiles. 
Patent analysis is an extremely effective and a versatile tool equipped with many implications of businesses, mergers, acquisitions, strategic planning, human resources (HR), licensing opportunities, business intelligence, competitive intelligence, R&D management, and more. It is a unique management tool designed for unraveling the strategic management, product, or services of a particular firm in the industry. The process of translating patent data of the company into a well-structured competitive intelligence data for technical competitiveness, potential competition, and future trends comprises the definition of patent analysis. 
In other words, Patent Analysis is to exploit the protective company information to help a firm or another company in strategic planning, evaluating technological forecasts, evaluating competitors’ data, and assessing its competitiveness in specific technologies and industrial areas. 
Patent analysis as a subject carries significant value when configuring the business strategy of global technological companies and wishing them to be at the forefront of the technology. In this case, analysts play a key role because they work on a variety of patent projects all over the world and help to summarize the content to produce it in a clear and in the most precise abstract. 
On this note, the team of research analysts at ResearchMoz is continually doing an applauding job by providing you deep insights into the competitive landscape of the Patent Analysis industry. We are here to help you with research reports on this section and much more. 
Browse through this section on our simplified website to gain a better understanding of the elaborated reports and make your purchase through the online portal in the most secured manner. For any further clarifications and requirements, you are free to get in touch with us at ResearchMoz.us.

Patent Analysis

Browse reports in Patent Analysis

Displaying 1 to 30 (of 635 records)
Amorolfine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May 2013   |   By - GenericsWeb
Amorolfine - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players....
$1200
Doripenem - Key patent, SPC, and data exclusivity expiry (44 country coverage)
May 2013   |   By - GenericsWeb
Doripenem - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This...
$1200
Abacavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Abacavir Abacavir indications: In combination...
$1200
Acitretin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Acitretin Acitretin indications:...
$1200
Adalimumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Adalimumab Adalimumab indications:...
$1200
Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Adefovir Adefovir indications: Treatment...
$1200
Alendronic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Alendronic Acid Alendronic Acid...
$1200
Alendronic Acid (Ext) - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Alendronic Acid (Ext) Alendronic Acid...
$1200
Alverine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Alverine Alverine indications: Adjunct in...
$1200
Amphotericin B - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Amphotericin B A mphotericin B...
$1200
Aripiprazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Aripiprazole Aripiprazole indications:...
$1200
Armodafinil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Armodafinil Armodafinil indications:...
$1200
Atovaquone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Atovaquone Atovaquone indications:...
$1200
Azelastine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Azelastine Azelastine indications:...
$1200
Barnidipine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Barnidipine Barnidipine indications: Hypertension...
$1200
Bevacizumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Bevacizumab Bevacizumab indications: In...
$1200
Bortezomib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Bortezomib Bortezomib indications:...
$1200
Brimonidine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Brimonidine Brimonidine indications:...
$1200
Brinzolamide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Brinzolamide Brinzolamide indications:...
$1200
Budesonide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Budesonide Budesonide indications:...
$1200
Caspofungin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Caspofungin Caspofungin indications:...
$1200
Celecoxib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Celecoxib Celecoxib indications: Familial...
$1200
Cetirizine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cetirizine Cetirizine indications:...
$1200
Cetuximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cetuximab Cetuximab indications:...
$1200
Ciprofloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ciprofloxacin Ciprofloxacin indications: Urinary tract...
$1200
Ciclosporin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ciclosporin Ciclosporin indications:...
$1200
Darbepoetin alfa - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Darbepoetin alfa Darbepoetin alfa...
$1200
Desvenlafaxine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Desvenlafaxine Desvenlafaxine indications: Depression...
$1200
Doxercalciferol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Doxercalciferol Doxercalciferol indications: Secondary...
$1200
Drospirenone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011   |   By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Drospirenone Drospirenone indications: Prevention of...
$1200
 
Displaying 1 to 30 (of 635 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData